echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Gastroenterology H: In elderly patients with inflammatory bowel disease, the risk of serious infections caused by vedolizumab is lower than that of anti-TNF-α drugs

    Clin Gastroenterology H: In elderly patients with inflammatory bowel disease, the risk of serious infections caused by vedolizumab is lower than that of anti-TNF-α drugs

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Elderly inflammatory bowel disease (senile inflammatory bowel disease, IBD) generally refers to patients with inflammatory bowel disease who are older than 60 or 65 years old at the time of onset.


    Elderly inflammatory bowel disease (senile inflammatory bowel disease, IBD) generally refers to patients with inflammatory bowel disease who are older than 60 or 65 years old at the time of onset.


     

    Researchers conducted a retrospective cohort study of adults over 65 years of age who had IBD and started anti-TNF-α drugs and vedolizumab


    Infect

    In total, there were 1152 patients treated with anti-TNF-α and 480 patients treated with vedolizumab


    It was shown that the risk of infection-related hospitalization in vedolizumab users was reduced, while the risk of infection -related infection in patients treated with anti-TNF-α was not significantly reduced


    This study confirmed that elderly patients with IBD who received vedolizumab had a lower risk of infection-related hospitalization compared with patients who started anti-tumor necrosis factor therapy


    Bharati Kochar.


    Vedolizumab is associated with a lower risk of serious infections than anti-TNF agents in older adults.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.